Patents/Assignees

Lee Moffitt Cancer Center And Research Institute, Inc.

4 patents in portfolio

US12617787utility2026
Merged Scaffold TAF1 Inhibitors
0 cites
US12600710utility2026
Beta-catenin and B-cell Lymphoma 9 (BCL9) Inhibitors
0 cites
US12564583utility2026
Small Molecules Against Cereblon to Enhance Effector T Cell Function
0 cites
US12215388utility2025
Theranostic Tools for Management of Pancreatic Cancer and Its Precursors
0 cites